胆固醇扭曲了粉样蛋白前体蛋白的跨膜Di-Gly区域
David Tzu-Wei Wang1,2, Tiffany Y C Tang1, Chun-Ting Kuo1,2
1Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan.
PNAS nexus
|June 2, 2023
概括
胆固醇通过改变细胞膜中粉样蛋白前体蛋白 (APP) 的结构来影响阿尔茨海默病风险. 这项研究揭示了膜胆固醇如何影响APP处理,影响阿尔茨海默病的发病过程.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 膜生物物理学 膜生物物理学
背景情况:
- 阿尔茨海默病 (AD) 通常是零星的,与高胆固醇等非基因组风险因素有关.
- 粉样蛋白-β (Aβ) ,来自粉样蛋白前体蛋白 (APP),在AD大脑中的聚合物.
- 胆固醇在零星AD病变发生中的作用需要对其对APP结构的影响进行调查.
研究的目的:
- 研究膜胆固醇含量如何影响 APP 跨膜区域的结构.
- 为了确定胆固醇是否调节通过γ-分泌酶的APP处理.
主要方法:
- 合成的 APP 跨膜区域与 Cys 突变用于旋转标记.
- 使用了电子自旋共振 (ESR) 光谱.
- 检查了不同胆固醇度的脂质体中的质结构.
主要成果:
- 胆固醇增加了10%的膜厚度,改变了的长度.
- APP的二甘氨酸区域 (Aβ36-40) 在对胆固醇的反应中显示出最显著的结构变化.
- 谱学证据表明,胆固醇调节了APP跨膜区域结构.
结论:
- 膜胆固醇显著影响APP跨膜区域的结构形状.
- 胆固醇对APP结构的影响为其在散发性阿尔茨海默病中的作用提供了分子解释.
- 这项研究提供了关于脂质组成如何影响APP处理和AD病变的见解.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Cholesterol: Significance and Regulation
608
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
608
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K
Multi-pass Transmembrane Proteins and β-barrels
5.4K
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
5.4K
GPI Anchoring of Proteins in the ER Membrane
4.2K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
4.2K
Alzheimer's Disease: Overview
539
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539


